Joshua Meyer, MD, Radiation Oncology, Philadelphia, PA, Fox Chase Cancer Center-American Oncologic Hospital

JoshuaE.MeyerMD

Radiation Oncology Philadelphia, PA

Gastrointestinal Cancer, Thoracic Cancer

Assistant Professor / Director Residency & Fellowship Programs

Dr. Meyer is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Meyer's full profile

Already have an account?

  • Office

    333 Cottman Avenue
    Fox Chase Cancer Center
    Philadelphia, PA 19111
    Phone(215) 728-6900
    Fax(215) 214-1629
  • Is this information wrong?

Education & Training

  • NewYork-Presbyterian/Queens
    NewYork-Presbyterian/QueensResidency, Radiation Oncology, 2006 - 2010
  • University of Massachusetts
    University of MassachusettsInternship, Internal Medicine, 2005 - 2006
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - Present
  • PA State Medical License
    PA State Medical License 2010 - 2022
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • How High Testosterone Levels Have Different Health Outcomes for Men and Women
    How High Testosterone Levels Have Different Health Outcomes for Men and WomenFebruary 14, 2020 01:34
  • New Study Supports the Decrease in the Age of the First Colonoscopy
    New Study Supports the Decrease in the Age of the First ColonoscopyFebruary 02, 2020 03:37
  • CivaTech Oncology Inc. Awarded up to $2.3M from NIH for Pancreatic Cancer Study with CivaSheet® Device
    CivaTech Oncology Inc. Awarded up to $2.3M from NIH for Pancreatic Cancer Study with CivaSheet® DeviceSeptember 20, 2016 10:44
  • Join now to see all

Professional Memberships

Hospital Affiliations